Study of Aldafermin (NGM282) in Participants With Impaired Renal Function
Clinical trial NCT04179630 · COMPLETED
Trial details
- NCT number
- NCT04179630
- Sponsor
- NGM Biopharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-08
- Primary completion
- 2019-12-04
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.